STAT1, STAT2 and IRF9 have all been implicated in regulating HLA-I expression in response to acute treatment of beta-cells with IFN, with altered STAT1 expression also observed in the islets of donors with T1D. The gene discussed is IRF9; the disease is type 1 diabetes mellitus.